LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

Search

Medpace Holdings Inc

Closed

SectorHealthcare

449.46 1.15

Overview

Share price change

24h

Current

Min

432.07

Max

451.15

Key metrics

By Trading Economics

Income

-11M

124M

Sales

-1.8M

707M

P/E

Sector Avg

26.908

50.102

EPS

4.28

Profit margin

17.53

Employees

6,300

EBITDA

-16M

148M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+0.43% upside

Dividends

By Dow Jones

Next Earnings

20 Jul 2026

Market Stats

By TradingEconomics

Market Cap

-2.9B

12B

Previous open

448.31

Previous close

449.46

News Sentiment

By Acuity

75%

25%

295 / 344 Healthcare

Medpace Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

23 Oct 2025, 15:15 UTC

Earnings

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

0.43% upside

12 Months Forecast

Average 447.5 USD  0.43%

High 495 USD

Low 393 USD

Based on 8 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

3

Buy

5

Hold

0

Sell

Sentiment

By Acuity

295 / 344 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat